190 results on '"Sun, Haowei Linda"'
Search Results
2. Practice patterns and outcomes of hemophagocytic lymphohistiocytosis in adults: a 2-decade provincial retrospective review
3. Development and internal validation of a clinical prediction model for the diagnosis of immune thrombocytopenia
4. Frequency and utility of bone marrow examination in relapsed/refractory immune thrombocytopenia
5. Switching to nonacog beta pegol in hemophilia B: Outcomes from a Canadian real‐world, multicenter, retrospective study
6. Incidence of bleeding and thromboembolism and impact on overall survival in adult patients with hemophagocytic lymphohistiocytosis: A 20‐year provincial retrospective cohort study
7. The impact of extended half‐life factor concentrates on patient reported health outcome measures in persons with hemophilia A and hemophilia B
8. Development and validation of a case definition to identify hemophilia in administrative data
9. Survival patterns among venous thromboembolism patients with hematologic malignancies in Alberta, Canada from 2003 to 2015
10. Validation of the PLASMIC score for predicting ADAMTS13 activity
11. Shared decision‐making related to treatment of haemophilia: A scoping review of influential factors and available support tools
12. Impact of inherited bleeding disorders on maternal bleeding and other pregnancy outcomes: A population‐based cohort study
13. THromboprophylaxis In Sickle Cell Disease with central venous catheters (THIS): an internal pilot randomised controlled trial protocol
14. Successful Ultrasound-Guided Spinal Anesthesia in a Patient With Severe Hemophilia A Undergoing Total Hip Arthroplasty
15. Cardiovascular Complications in Patients with Renal Disease
16. Management and Outcomes of Venous Thromboembolism in Adults with Immune Thrombocytopenia
17. The Empower Study - Design of a Randomized Clinical Trial to Assess the Efficacy and Safety of a Plasma-Derived Von Willebrand Factor / Factor VIII Concentrate for Heavy Menstrual Bleeding in Women with Von Willebrand Disease
18. Arterial Thromboembolism Is Prevalent and Often Suboptimally Managed in Immune Thrombocytopenia
19. Comparison of Activated Clotting Time to Hepcon Protamine Titration for Anticoagulation Management during Cardiopulmonary Bypass Surgery in a Patient with Severe Hemophilia a on Emicizumab Prophylaxis
20. Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: a multicenter retrospective analysis
21. Increased acute care utilisation, comorbidities and mortality in adults with haemophilia: A population‐based cohort study from 2012 to 2019
22. Patient powered prophylaxis: A 12‐month study of individualized prophylaxis in adults with severe haemophilia A
23. Diabetes, hepatitis C and human immunodeficiency virus influence hypertension risk differently in cohorts of haemophilia patients, veterans and the general population
24. Blood pressure in persons with haemophilia with a focus on haemophilia‐specific risk factors
25. Validation of the HScore and the HLH ‐2004 diagnostic criteria for the diagnosis of hemophagocytic lymphohistiocytosis in a multicenter cohort
26. Risk of diabetes in haemophilia patients compared to clinic and non‐clinic control cohorts
27. Treatment Patterns and Outcomes of Second-Line Therapy in Adult Immune Thrombocytopenia: A Provincial Retrospective Cohort Study
28. An investigation of the measurement properties of the physiotherapy therapeutic relationship measure in patients with musculoskeletal conditions
29. Outcomes and Health Resource Utilization Among Second-Line Therapies for Immune Thrombocytopenia: A Provincial Retrospective Cohort Study
30. Impact of Inherited Bleeding Disorders on Maternal Bleeding and Other Pregnancy Outcomes: A Population-Based Cohort Study
31. Geographic Remoteness Is Associated with Increased Blood Product Utilization and Higher Rates of Hospitalization and Deaths in Adults with Immune Thrombocytopenia
32. Trends of outcomes and healthcare utilization following orthopaedic procedures in adults with haemophilia: A 3‐decade retrospective review
33. Measuring therapeutic relationship in physiotherapy: conceptual foundations
34. All‐cause mortality and causes of death in persons with haemophilia: A systematic review and meta‐analysis
35. Prevalence and Risk Factors of Diagnostic Delays in Acquired Hemophilia A
36. Rates and Predictors of Prophylaxis in Women with Von Willebrand Disease and Heavy Menstrual Bleeding
37. Appropriateness of Immunosuppression and Blood Product Utilization in Acquired Hemophilia A: A Multicentre Provincial Practice Audit
38. Case Series of Paraspinal Extramedullary Hematopoiesis in Transfusion-Dependent Thalassemia Treated with Luspatercept
39. Predictors of Diagnostic Delays and Loss to Follow-up in Women with Von Willebrand Disease
40. Factor product utilization and health outcomes in patients with haemophilia A and B on extended half‐life concentrates: A Canadian observational study of real‐world outcomes
41. Observational study of efficacy and safety of human cell line–derived recombinant factor VIII in Canadian adults with moderately severe and severe haemophilia A
42. Development of the Physiotherapy Therapeutic Relationship Measure
43. Real‐world data of immune tolerance induction using recombinant factor VIII Fc fusion protein in patients with severe haemophilia A with inhibitors at high risk for immune tolerance induction failure: A follow‐up retrospective analysis
44. The Clinical Conundrum of Managing Ischemic Stroke in Patients with Immune Thrombocytopenia
45. Survival Pattern Among Venous Thromboembolism (VTE) Patients with Hematologic Malignancy in Alberta, Canada from 2003 to 2015
46. Validation of the Plasmic Score for Predicting ADAMTS13 Activity < 10% in Patients Admitted to Hospitals in Alberta with Suspected Thrombotic Thrombocytopenic Purpura
47. Erectile dysfunction in patients with haemophilia
48. Outcomes indicators and processes in transitional care in adolescents with haemophilia: A Delphi survey of Canadian haemophilia care providers
49. Real‐world data of immune tolerance induction using recombinant factor VIII Fc fusion protein in patients with severe haemophilia A with inhibitors at high risk for immune tolerance induction failure: A follow‐up retrospective analysis.
50. Observational Study of Real-World Factor Utilization and Health Outcomes in Patients with Hemophilia in Canada
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.